DoseRoutine supplement library logoDoseRoutine
supplementNot FDA-approvedSold as a probiotic dietary supplement

Akkermansia muciniphilaBenefits, Dosage & Interactions

Also known as: akkermansia, A. muciniphila, pasteurized akkermansia

Akkermansia muciniphila is a supplement typically taken orally or as directed. It is most commonly tracked for gut health and metabolic. It is typically taken in the morning. Dose, response, and interaction risk vary by individual, so use should be reviewed with a clinician.

How much Akkermansia muciniphila do people take?

The 2019 pilot trial used 10^10 bacteria daily, live or pasteurized; the pasteurized form carried the measured metabolic signals. Route reported: Oral capsule. Frequency reported: Once daily in the published protocol. These are amounts documented in the cited studies and labels for Akkermansia muciniphila — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.

See the full reported protocol and its sources

Researched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.

Evidence: Moderate — One published human randomized trial; results not yet replicated.
Evidence strengthModerate · 3/4
PreclinicalStrong human evidence

One published human randomized trial; results not yet replicated.

Plasma half-life
Not applicable — a live or pasteurized bacterial strain
Typical timing
in the morning
Default unit
mg

What published protocols report

Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.

Reported amounts
The 2019 pilot trial used 10^10 bacteria daily, live or pasteurized; the pasteurized form carried the measured metabolic signals[1][2]
Route studied
Oral capsule[1][2]
Frequency
Once daily in the published protocol[1][2]
Cycle length
3 months in the pilot trial[1][2]
Half-life
Not applicable — a live or pasteurized bacterial strain[1][2]
Storage
Per label; many products require refrigeration[1][2]

Reported for Akkermansia muciniphila in the cited sources. Published ranges are not dosing advice.

References & evidence

Documents the Akkermansia muciniphila entry is written from. Each number matches an inline marker above.

  1. [1]Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory studyDepommier C, et al. · Nature Medicine · 2019 · Peer-reviewed · PMID 31263284
  2. [2]Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphilaCani PD, de Vos WM · Frontiers in Microbiology · 2017 · Peer-reviewed · PMID 28955325

What is Akkermansia muciniphila?

Akkermansia muciniphila is catalogd in DoseRoutine as a supplement. A detailed evidence-based summary is being prepared from NIH, Mayo Clinic, FDA label and PubChem sources.

What interacts with Akkermansia muciniphila?

Documented interactions for Akkermansia muciniphila: the other compound, the severity and confidence of the interaction, what happens, and what to do.
Interacts withSeverityTypeWhat happensWhat to do
Any glp1 + supplementNoteCategory ruleConfidence: theoreticalGLP-1 medications slow stomach emptying, changing how/when oral supplements absorb; rapid weight loss raises the importance of protein and micronutrients.Source pendingTime oral supplements when nausea is lowest; prioritize protein and micronutrients; discuss with your provider.
Any supplement + medicationNoteCategory ruleConfidence: theoreticalSome supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pendingSpecific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.

Frequently asked questions about Akkermansia muciniphila

Akkermansia muciniphila is a supplement. It is also known as akkermansia, A. muciniphila, and pasteurized akkermansia. What follows is drawn from peer-reviewed literature indexed on PubMed, FDA label text where a label exists, and NIH reference records.

Akkermansia muciniphila is commonly discussed in the context of supporting gut-health and metabolic. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.

For Akkermansia muciniphila, it is typically taken in the morning. Always follow the specific dose your clinician or the product label prescribes.

Akkermansia muciniphila carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Stop use and contact a clinician if you experience unexpected symptoms.

Akkermansia muciniphila is a supplement, and interactions are possible with prescriptions, hormones, peptides and other supplements in the same routine. Because Akkermansia muciniphila is usually taken in the morning, most avoidable conflicts come from what else lands in that same window. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Akkermansia muciniphila with no sign-up.

Combining a supplement like Akkermansia muciniphila with TRT is usually a question of labs rather than a blanket yes or no: the ester, injection interval and any aromatase inhibitor all change the answer. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions

Each peptide class carries its own profile against Akkermansia muciniphila: a healing peptide raises different questions than a GLP-1 agonist or a growth-hormone secretagogue. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.

Published frequency for Akkermansia muciniphila varies by protocol and formulation, so the label or prescription is what sets it. It is typically taken in the morning. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps

The effect of a missed dose of Akkermansia muciniphila depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.

For Akkermansia muciniphila the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.

The 2019 pilot trial used 10^10 bacteria daily, live or pasteurized; the pasteurized form carried the measured metabolic signals. Route reported: Oral capsule. Frequency reported: Once daily in the published protocol. These are amounts documented in the cited studies and labels for Akkermansia muciniphila — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.

Verify at

Publisher search links for Akkermansia muciniphila. These are places to check the information — they are not citations, so they are not numbered.

DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.

What is the short answer on Akkermansia muciniphila?

Plain-text summary, safe to quote verbatim:

Akkermansia muciniphila is a supplement typically taken orally or as directed. It is most commonly tracked for gut health and metabolic. It is typically taken in the morning. Dose, response, and interaction risk vary by individual, so use should be reviewed with a clinician.
Source: DoseRoutine — https://doseroutine.com/library/akkermansia-muciniphila

Cite this page

Using this in an article, AI answer, or research note? Please attribute:

DoseRoutine. (2026). Akkermansia muciniphila — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/akkermansia-muciniphila
Canonical URL

What compounds are similar to Akkermansia muciniphila?

Others in the supplement category or studied for the same goals.

Track Akkermansia muciniphila in DoseRoutine

Add it to your stack. We'll schedule doses, check interactions against everything else you take, and remind you at the right time.

Sign up free →

Latest research from DoseRoutine

Browse all DoseRoutine research updates

Track Akkermansia Muciniphila in your own routine

Add Akkermansia Muciniphila to your stack, get reminders at the right times, and see interaction notes with everything else you take. Free to start — no card needed.

Track Akkermansia Muciniphila freeSign in